Drilling Tests Main Showing Boundaries and First Holes at Steep Creek Zinc-Lead Target; Assays Pending
Drilling Tests Main Showing Boundaries and First Holes at Steep Creek Zinc-Lead Target; Assays Pending
Originally published via Source Article.
Drilling Tests Main Showing Boundaries and First Holes at Steep Creek Zinc-Lead Target; Assays Pending
Drilling Tests Main Showing Boundaries and First Holes at Steep Creek Zinc-Lead Target; Assays Pending
Originally published via Source Article.
TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (FSE: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, announces is pleased to announce its participation in the upcoming 3rd Annual ArcStone-Kingswood Growth Summit in Toronto, taking place on September 16, 2026, at the Sheraton Center Toronto Hotel. Anthony Durkacz, Co-founder and Executive Co-chairman of the board of Quantum BioPharma, will be presenting on the company’s recent milestones and future growth strategy.
Originally published via Source Article.
TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) — Volaris Group today announced the acquisition of Matrix Booking Limited, a UK-based provider of meeting room and desk booking software used by government departments, NHS organizations and other public sector bodies across the United Kingdom.
Originally published via Source Article.
Drilling Tests Main Showing Boundaries and First Holes at Steep Creek Zinc-Lead Target; Assays Pending
Drilling Tests Main Showing Boundaries and First Holes at Steep Creek Zinc-Lead Target; Assays Pending
Originally published via Source Article.
TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (FSE: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, announces is pleased to announce its participation in the upcoming 3rd Annual ArcStone-Kingswood Growth Summit in Toronto, taking place on September 16, 2026, at the Sheraton Center Toronto Hotel. Anthony Durkacz, Co-founder and Executive Co-chairman of the board of Quantum BioPharma, will be presenting on the company’s recent milestones and future growth strategy.
Originally published via Source Article.

TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) — Allied Properties REIT (“Allied”) (TSX:AP.UN) announced today that the Trustees of Allied have declared a distribution of $0.06 per unit for the month of September 2026, representing $0.72 per unit on an annualized basis. The distribution will be payable on October 15, 2026, to unitholders of record as at September 29, 2026.

Homes by Avi named Alberta Builder of the Year for a second straight year, earning five BILD Alberta Awards for design, efficiency and service.

Mackenzie Hughes Named Chief Executive Officer and Ambassador Mark Dybul, M.D. Named Chairman
Mackenzie Hughes Named Chief Executive Officer and Ambassador Mark Dybul, M.D. Named Chairman

CIRI’s 40th Annual Investor Relations Conference will take place in Kelowna, British Columbia, from June 16 to 18, 2027. Registration is now open.

Following a successful pilot, Guestologie deploys real-time guest recognition across all nine Ruth’s Chris locations run by Big Steaks Management.